- Usefulness of presepsin in predicting the prognosis of patients with sepsis or septic shock: a retrospective cohort study
-
Jeong Suk Koh, Yoon Joo Kim, Da Hyun Kang, Jeong Eun Lee, Song-I Lee
-
Yeungnam Univ J Med. 2021;38(4):318-325. Published online June 15, 2021
-
DOI: https://doi.org/10.12701/yujm.2021.01018
-
-
5,984
View
-
139
Download
-
6
Crossref
-
 Abstract
 PDF
- Background
The diagnosis and prediction of prognosis are important in patients with sepsis, and presepsin is helpful. In this study, we aimed to examine the usefulness of presepsin in predicting the prognosis of sepsis in Korea.
Methods
Patients diagnosed with sepsis according to the sepsis-3 criteria were recruited into the study and classified into surviving and non-surviving groups based on in-hospital mortality. A total of 153 patients (33 and 121 patients with sepsis and septic shock, respectively) were included from July 2019 to August 2020.
Results
Among the 153 patients with sepsis, 91 and 62 were in the survivor and non-survivor groups, respectively. Presepsin (p=0.004) and lactate (p=0.003) levels and the sequential organ failure assessment (SOFA) scores (p<0.001) were higher in the non-survivor group. Receiver operating characteristic curve analysis revealed poor performances of presepsin and lactate in predicting the prognosis of sepsis (presepsin: area under the curve [AUC]=0.656, p=0.001; lactate: AUC=0.646, p=0.003). The SOFA score showed the best performance, with the highest AUC value (AUC=0.751, p<0.001). The prognostic cutoff point for presepsin was 1,176 pg/mL. Presepsin levels of >1,176 pg/mL (odds ratio [OR], 3.352; p<0.001), lactate levels (OR, 1.203; p=0.003), and SOFA score (OR, 1.249; p<0.001) were risk factors for in-hospital mortality.
Conclusion
Presepsin levels were higher in non-survivors than in survivors. Thus, presepsin may be a valuable biomarker in predicting the prognosis of sepsis.
-
Citations
Citations to this article as recorded by  - Free Radical–Associated Gene Signature Predicts Survival in Sepsis Patients
Anlin Feng, Marissa D. Pokharel, Ying Liang, Wenli Ma, Saurabh Aggarwal, Stephen M. Black, Ting Wang
International Journal of Molecular Sciences.2024; 25(8): 4574. CrossRef - Presepsin in Critical Illness: Current Knowledge and Future Perspectives
Paolo Formenti, Miriam Gotti, Francesca Palmieri, Stefano Pastori, Vincenzo Roccaforte, Alessandro Menozzi, Andrea Galimberti, Michele Umbrello, Giovanni Sabbatini, Angelo Pezzi
Diagnostics.2024; 14(12): 1311. CrossRef - Diagnostic and Prognostic Roles of C-Reactive Protein, Procalcitonin, and Presepsin in Acute Kidney Injury Patients Initiating Continuous Renal Replacement Therapy
Suyeon Han, Moo-Jun Kim, Ho-Joon Ko, Eu-Jin Lee, Hae-Ri Kim, Jae-Wan Jeon, Young-Rok Ham, Ki-Ryang Na, Kang-Wook Lee, Song-I. Lee, Dae-Eun Choi, Heyrim Park
Diagnostics.2023; 13(4): 777. CrossRef - Existe Relação entre Miocardite Aguda e a Permeabilidade Intestinal? Dois Biomarcadores nos Ajudam a Responder a esta Pergunta
Fernando Arturo Effio Solis, Adriana Brentegani, Marcelo Luiz Campos Vieira
Arquivos Brasileiros de Cardiologia.2023;[Epub] CrossRef - Biomarkers in sepsis-looking for the Holy Grail or chasing a mirage!
Neelmani Ahuja, Anjali Mishra, Ruchi Gupta, Sumit Ray
World Journal of Critical Care Medicine.2023; 12(4): 188. CrossRef - Presepsin as a Novel Biomarker in predicting In‐hospital Mortality in Patients With COVID‐19 Pneumonia
Hebatallah Hany Assal, Safaa Mohamed Abdelrahman, Maha AlyAlden Abdelbasset, Mai Abdelaziz, Irene Mohamed Sabry, Marwa Moawad Shaban
International Journal of Infectious Diseases.2022; 118: 155. CrossRef
|
E-Submission
Yeungnam University College of Medicine
